Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia

被引：0

作者：

Tedeschi, Alessandra ^{[1
]}

Rossi, Davide ^{[2
]}

Coscia, Marta ^{[3
]}

Vismara, Eleonora ^{[1
]}

Petrizzi, Valeria Belsito ^{[4
]}

Orlandi, Ester ^{[5
]}

Cascavilla, Nicola ^{[6
]}

Scarfo, Lydia ^{[7
]}

Motta, Marina ^{[8
]}

Vitale, Candida ^{[3
]}

Ricci, Francesca ^{[1
]}

De Paoli, Lorenzo ^{[2
]}

D'Arco, Alfonso Maria ^{[4
]}

Gallamini, Andrea ^{[9
]}

Gaidano, Gianluca ^{[10
]}

Morra, Enrica ^{[1
]}

Massaia, Massimo ^{[3
]}

Montillo, Marco ^{[1
]}

机构：

[1] Osped Niguarda Ca Granda, Dept Hematol, Milan, Italy

[2] Amedeo Avogadro Univ, Dept Hematol, Novara, Italy

[3] Univ Turin, Dept Med & Expt Oncol, Sect Hematol, Turin, Italy

[4] Nocera Inferiore Hosp, Dept Internal Med, Nocera Inferiore, Italy

[5] Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy

[6] IRCCS, Dept Hematol, San Giovanni Rotondo, Italy

[7] Ist Sci San Raffaele, Lymphoma Unit, Dept Oncohematol, Milan, Italy

[8] Brescia Hosp, Spedali Civili, Dept Hematol, Brescia, Italy

[9] Santa Croce Hosp, Dept Hematol, Cuneo, Italy

[10] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.2898.2898

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2898

引用

页数：2

共 50 条

[31] Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
Veliz, Marays
Pinilla-Ibarz, Javier
CANCER CONTROL, 2012, 19 (01) : 37 - 53
[32] Bendamustine in chronic lymphocytic leukemia: the future is combination therapy
Friedberg, Jonathan W.
LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1399 - 1400
[33] Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia
Abou Zahr, Abdallah
Bose, Prithviraj
Keating, Michael J.
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 857 - 873
[34] Management of relapsed/refractory chronic lymphocytic leukemia
Tomowiak, Cecile
HEMATOLOGIE, 2024, 30 : 19 - 27
[35] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Odetola, Oluwatobi
Ma, Shuo
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 130 - 143
[36] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Oluwatobi Odetola
Shuo Ma
Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
[37] Combination of fludarabine (FAMP) cyclophosphamide (CTX) and alemtuzumab for patients with relapsed chronic lymphocytic leukemia (CLL).
Tedeschi, A
Montillo, M
Miqueleiz, S
Draisci, M
Ricci, F
Scarpati, B
Mura, ME
Crugnola, M
Morra, E
BLOOD, 2005, 106 (11) : 341B - 341B
[38] BENDAMUSTINE MONOTHERAPY IN ELDERLY PATIENTS AFFECTED BY RELAPSED OR REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Lucania, A.
Esposito, M.
Della Cioppa, P.
Improta, S.
Mastrullo, L.
HAEMATOLOGICA, 2015, 100 : 74 - 74
[39] Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Fischer, Kirsten
Cramer, Paula
Busch, Raymonde
Stilgenbauer, Stephan
Bahlo, Jasmin
Schweighofer, Carmen D.
Boettcher, Sebastian
Staib, Peter
Kiehl, Michael
Eckart, Michael J.
Kranz, Gabriele
Goede, Valentin
Elter, Thomas
Buehler, Andreas
Winkler, Dirk
Kneba, Michael
Doehner, Hartmut
Eichhorst, Barbara F.
Hallek, Michael
Wendtner, Clemens-Martin
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3559 - 3566
[40] Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic Leukemia
Gladstone, Douglas
Andre, Marc
Jan Zaucha
Assouline, Sarit
Bellam, Naresh
Cascavilla, Nicole
Jourdan, Eric
Panwalkar, Amit
Patti, Caterina
Schulte, Clemens
Zaja, Francesco
Goswami, Trishna
Elgeioushi, Nairouz
Streicher, Katie
Bao, Haifeng
Spaner, David
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →